Acquired, non-amyloid related factor X deficiency: review of the literature.

作者: G. LEE , W. DUAN-PORTER , A. METJIAN

DOI: 10.1111/J.1365-2516.2012.02773.X

关键词:

摘要: Summary.  Factor X (FX) deficiency is a rare coagulopathy due to congenital (Stuart–Prower disease) or in association with primary amyloidosis. Acquired and isolated FX occurring the absence of plasma cell dyscrasia has only been infrequently described. After recently diagnosing treating case acquired, deficiency, we embarked upon review literature help guide clinicians who may face this clinical situation. The was reviewed identify cases isolated, acquired unrelated use vitamin K antagonists, There were 34 identified, malignancy, drug exposure infection. majority described (38%) preceded by non-specific respiratory viral illness. initial presentation variable, ranging from no bleeding life-threatening haemorrhage. Twenty per cent patients had musculoskeletal resembling haemophilia. Both prothrombin time activated partial thromboplastin markedly prolonged nearly all patients. In 26% patients, specific inhibitor identified. Numerous therapies have utilized including high-dose glucocorticoids, exchange fresh frozen intravenous immunoglobulin. 18% resolved spontaneously. All achieved complete recovery. factor disorder, commonly associated preceding illness circulating inhibitor. Although multiple treatment modalities variable success, many cases, it self-limited condition.

参考文章(43)
Patricia E. Mulhare, Paula B. Tracy, Elizabeth A. Golden, Richard F. Branda, Edwin G. Bovill, A case of acquired factor X deficiency with in vivo and in vitro evidence of inhibitor activity directed against factor X. American Journal of Clinical Pathology. ,vol. 96, pp. 196- 200 ,(1991) , 10.1093/AJCP/96.2.196
K Mertens, R M Bertina, Pathways in the activation of human coagulation factor X. Biochemical Journal. ,vol. 185, pp. 647- 658 ,(1980) , 10.1042/BJ1850647
Richard A. Edgin, Earl N. Metz, John J. Fromkes, Floyd M. Beman, Acquired factor X deficiency with associated defects in platelet aggregation: A response to corticosteroid therapy The American Journal of Medicine. ,vol. 69, pp. 137- 139 ,(1980) , 10.1016/0002-9343(80)90512-4
Abdallah Jm, Hanrahan Lr, Sallah S, Nguyen Np, Acquired Hemophilia in Patients With Hematologic Malignancies Archives of Pathology & Laboratory Medicine. ,vol. 124, pp. 730- 734 ,(2000) , 10.1043/0003-9985(2000)124<0730:AHIPWH>2.0.CO;2
Irving S. Wright, The nomenclature of blood clotting factors. Canadian Medical Association Journal. ,vol. 86, pp. 373- 374 ,(1962)
Flora Peyvandi, PM Mannucci, None, Rare coagulation disorders Thrombosis and Haemostasis. ,vol. 82, pp. 1207- 1214 ,(1999) , 10.1055/S-0037-1614361
Peyvandi, Mannucci, Lak, Abdoullahi, Zeinali, Sharifian, Perry, CONGENITAL FACTOR X DEFICIENCY: SPECTRUM OF BLEEDING SYMPTOMS IN 32 IRANIAN PATIENTS British Journal of Haematology. ,vol. 102, pp. 626- 628 ,(1998) , 10.1046/J.1365-2141.1998.00806.X
S. S. Acharya, A. Coughlin, D. M. Dimichele, , Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias Journal of Thrombosis and Haemostasis. ,vol. 2, pp. 248- 256 ,(2004) , 10.1111/J.1538-7836.2003.T01-1-00553.X
M. Karimi, Hirad Yarmohammadi, R. Ardeshiri, Hooman Yarmohammadi, Inherited coagulation disorders in southern Iran Haemophilia. ,vol. 8, pp. 740- 744 ,(2002) , 10.1046/J.1365-2516.2002.00699.X